Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.

Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL.

J Am Coll Cardiol. 2008 May 13;51(19):1857-64. doi: 10.1016/j.jacc.2008.01.041.

2.

Natriuretic peptides in heart failure and acute coronary syndrome.

Gaggin HK, Januzzi JL Jr.

Clin Lab Med. 2014 Mar;34(1):43-58, vi. doi: 10.1016/j.cll.2013.11.007. Epub 2014 Jan 14. Review.

PMID:
24507786
3.

Biomarkers and diagnostics in heart failure.

Gaggin HK, Januzzi JL Jr.

Biochim Biophys Acta. 2013 Dec;1832(12):2442-50. doi: 10.1016/j.bbadis.2012.12.014. Epub 2013 Jan 9. Review.

4.

The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting.

Roberts E, Ludman AJ, Dworzynski K, Al-Mohammad A, Cowie MR, McMurray JJ, Mant J; NICE Guideline Development Group for Acute Heart Failure.

BMJ. 2015 Mar 4;350:h910. doi: 10.1136/bmj.h910. Review.

5.

Clinical Applications of Biomarkers in Atrial Fibrillation.

Chang KW, Hsu JC, Toomu A, Fox S, Maisel AS.

Am J Med. 2017 Dec;130(12):1351-1357. doi: 10.1016/j.amjmed.2017.08.003. Epub 2017 Aug 16. Review.

PMID:
28822701
6.

Role of biomarkers in patients with dyspnea.

Gori CS, Magrini L, Travaglino F, Di Somma S.

Eur Rev Med Pharmacol Sci. 2011 Feb;15(2):229-40. Review.

PMID:
21434492
7.

Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.

Maisel AS, Duran JM, Wettersten N.

Heart Fail Clin. 2018 Jan;14(1):13-25. doi: 10.1016/j.hfc.2017.08.002. Review.

PMID:
29153197
8.

Natriuretic peptide hormone measurement in acute coronary syndromes.

Maewal P, de Lemos JA.

Heart Fail Rev. 2003 Oct;8(4):365-8. Review.

PMID:
14574059
9.

Chronic heart failure in the elderly: a current medical problem.

Nessler J, Skrzypek A.

Pol Arch Med Wewn. 2008 Oct;118(10):572-80. Review.

10.

Prognostic value of cardiac biomarkers in the risk stratification of syncope: a systematic review.

Thiruganasambandamoorthy V, Ramaekers R, Rahman MO, Stiell IG, Sikora L, Kelly SL, Christ M, Claret PG, Reed MJ.

Intern Emerg Med. 2015 Dec;10(8):1003-14. doi: 10.1007/s11739-015-1318-1. Epub 2015 Oct 23. Review.

PMID:
26498335
11.

Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers.

Jessani S, Lip GY.

J Card Fail. 2006 Oct;12(8):641-3. Review. No abstract available.

PMID:
17045184
12.

Biomarkers of heart failure.

Taub PR, Gabbai-Saldate P, Maisel A.

Congest Heart Fail. 2010 Jul;16 Suppl 1:S19-24. doi: 10.1111/j.1751-7133.2010.00168.x. Review.

13.

Novel biomarkers predicting cardiac function after acute myocardial infarction.

Feistritzer HJ, Klug G, Reinstadler SJ, Reindl M, Mayr A, Mair J, Metzler B.

Br Med Bull. 2016 Sep;119(1):63-74. doi: 10.1093/bmb/ldw027. Epub 2016 Jul 14. Review.

PMID:
27418651
14.

Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective.

Dahdah N, Fournier A.

Diagnostics (Basel). 2013 Jan 10;3(1):1-12. doi: 10.3390/diagnostics3010001. Review.

Supplemental Content

Support Center